+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hemorrhoids Market By Product Type, By Disease Type, By Treatment Type, By Route of Administration, and By End-user, Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035- Product Image
Hemorrhoids Market By Product Type, By Disease Type, By Treatment Type, By Route of Administration, and By End-user, Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035- Product Image
New

Hemorrhoids Market By Product Type, By Disease Type, By Treatment Type, By Route of Administration, and By End-user, Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

  • PDF Icon

    Report

  • 205 Pages
  • May 2025
  • Region: Global
  • IHR Insights
  • ID: 6084321
10% Free customization
Description Jump to:
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Hemorrhoids market accounted for USD 1.46 billion in 2024 and is expected to reach USD 3.73 billion by 2035, growing at a CAGR of around 8.9% between 2025 and 2035. Medication for hemorrhoids refers to products and remedial therapies developed specifically for managing and alleviating symptomatic conditions associated with swollen and inflamed veins in the rectum and anus. These include a full spectrum of offerings such as over-the-counter creams, suppositories, devices, surgical interventions, and so on. The market is primarily driven by a sedentary lifestyle, an aging population, and the knowledge of available treatments. Innovations in minimally invasive procedures are improving patient outcomes and recovery times.

Increased demand for self-care solutions and over-the-counter products is also changing the shape of the industry. Further, the growing access to health care in developing countries also opens new avenues for growth. Generally, the outlook for the industry continues to remain optimistic over the long run, as such a constantly increasing demand would support technological advancements for the long-term development of this market.

Increasing Prevalence Due to Lifestyle Factors

Lifestyle changes cause an increased prevalence over time. Modern society is turning sedentary; there are increasing hours of sitting with little associated physical activity, which plays a key role in increasing the incidence of hemorrhoids. Poor dietary habits consisting of an almost negligible amount of fiber and heavy consumption of processed foods result in constipation, which is a major risk factor. Moreover, obesity and advancing age worsen the prevalence of the condition.

These aspects all put up the demand for effective hemorrhoid treatment, preventive, and therapeutic. Healthcare practitioners are widely stressing the teachings of lifestyle modifications with the treatment course of medical intervention as part of their holistic approach to reducing recurrence and improving patient outcomes. Thus, the market sees a case of growth due to both rising cases and proactive management.

Cost Concerns for Advanced Treatment

While minimally invasive procedures present a series of advantages, they often place a high burden on a patient. Insurance coverage varies widely for some minimally invasive treatments; thus, patients are left with quite a big out-of-pocket payment. This load is sometimes too heavy for patients seeking timely medical intervention. As a result, some patients resort to over-the-counter medicines and alternative treatments, which might not yield effective results. The cost factor puts a barrier in front of healthcare professionals recommending their best treatment. Another roadblock affecting the widespread acceptability of the advanced treatments is this financial impasse. A solution to affordability would yield good returns for the market and improved care for its patients.

Emergence of Over-the-Counter (OTC) Products

The demand for self-care solutions is calling for a rise in over-the-counter hemorrhoid products as creams, ointments, or suppositories, that give easy relief from mild symptoms. They have turned to the production of new formulations of these products. The availability of these products in pharmacies and online platforms guarantees their widespread access and greatly expands the selling to marketing strategies that focus on education and awareness. The OTC segment is actually where much growth occurs because of this trend in people looking for cost-effective private ways of treating ailments. It gives good room for market players operating in this segment to present an offer to a large audience.

Segment Analysis

Disease classification includes internal, external, prolapsed, and thrombosed hemorrhoids. Internal hemorrhoids are situated inside the rectum and are usually painless, except for bleeding. External hemorrhoids exist under the skin around the anus and may be extremely painful. Prolapsed hemorrhoids protrude outwards from the anal opening and may need to be pushed back in by hand or surgically removed. Thrombosed hemorrhoids undergo clot formation, resulting in severe pain and swelling. The differentiation between these is vital for choosing the correct treatment. In treating different types and grades of hemorrhoids, interventions are tailored accordingly. This classification affects clinical and product development.

Treatment types divide into surgical and non-surgical approaches. Non-surgical treatments, such as systemic medications and minimally invasive procedures, are preferred in mild-to-moderate cases. Surgical treatments occur if there is a severe case or if the condition has recurred, including hemorrhoidectomy and stapled hemorrhoidopexy. The newer surgical techniques were developed to reduce the pain during the surgery and shorten the recovery time. On treatment choice, patient preferences, severity of symptoms, and suggestions from their healthcare provider are considered. The availability of multiple treatment options is beneficial to patient care. Research is being conducted to improve the outcomes and reduce complications for all types of treatments.

Regional Analysis

North America certainly leads the hemorrhoids market. The prevalent condition propagates in close connection with a sound healthcare infrastructure. The region benefits from widespread awareness and access to various treatment modalities. The insurance and reimbursement policies are tailormade towards affordability for patients. Continuous research and development efforts have permitted innovative product offerings-healthcare providers emphasize early diagnosis and intervention in disease treatment. Patient education campaigns aimed at lessening stigmatization encourage treatment-seeking behavior. All these factors combined will support this market challenge and growth in North America.

Competitive Landscape

The hemorrhoids market possesses several marketing players who are vying for a share of the market through innovations and strategic initiatives. The medical companies, such as Medtronic plc, Boston Scientific Corporation, Johnson & Johnson, and Stryker Corporation, are concentrating on developing advanced treatment devices and surgical instruments through research and development.

Considerable resources are allocated within these firms for the research and development of minimally invasive solutions aimed at improving patient comfort and adequate recovery. Strategies such as collaboration, mergers, and acquisitions are common to extend products that add to the companies' portfolios and increase their reach in the global marketplace.

The marketing strategy would incorporate the promotion of such treatment alternatives to health professionals and the public. The regulatory approvals and compliance with international safety standards are imperative for launching its products in the market. The competitive edge changes rapidly, with efforts directed at maintaining technological superiority and improved patient outcomes. This rivalry feeds on innovation initiatives, forming the bedrock upon which the development of the hemorrhoids market rests.

Report Coverage:

By Product Type

  • Drugs
  • OTC
  • Prescription Drugs
  • Devices
  • Hemorrhoid Banding Devices
  • Laser Treatment Devices
  • Cryotherapy Devices
  • Supplements

By Disease Type

  • Internal Hemorrhoids
  • External Hemorrhoids
  • Prolapsed Hemorrhoids
  • Thrombosed Hemorrhoids

By Treatment Type

  • Surgical Treatments
  • Hemorrhoidectomy
  • Stapled Hemorrhoidopexy
  • Non-surgical Treatments
  • Medications
  • Minimally Invasive Procedures

By Route of Administration

  • Topical
  • Oral
  • Injectable

By End-user

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings

Table of Contents

1. Methodology & Report Coverage
1.1. Definition & Objective
1.2. Market Evaluation & forecast parameter
1.3. Research Methodology
1.4. Data Validation Sources
1.4.1. Secondary Research
1.4.2. Primary Research
2. Market Overview
3. Hemorrhoids Market: Market Dynamics
3.1. Executive Summary
3.2. Market Driving Factors
3.2.1. The rising incidence of hemorrhoids is significantly driven by unhealthy lifestyle choices.
3.2.2. The expansion of online health platforms is facilitating greater access to hemorrhoid treatment products.
3.2.3. Continuous innovations are leading to more effective and less invasive treatment methodologies.
3.3. Key industry pitfalls & challenges
3.3.1. Many individuals hesitate to seek treatment due to societal stigma surrounding hemorrhoids.
3.3.2. Insurance plans often do not cover many advanced treatment options, limiting access for patients.
3.3.3. The expensive nature of cutting-edge treatment options may hinder broader patient adoption.
3.4. Market Opportunities
3.4.1. The rise of telehealth services allows for easier access to consultations regarding hemorrhoid issues.
3.4.2. Increased investment in R&D can lead to innovative solutions and improved treatment experiences for patients.
3.4.3. Increased demand for over-the-counter products offers opportunities for market expansion and innovation.
3.5. Porter’s Five Forces Analysis
3.6. PESTLE Analysis
3.7. Regulatory landscape
3.8. Investment Landscape
3.9. ESG Scenario
3.10. Competitive landscape
3.10.1. Company Market Share
3.10.2. Market Positioning
3.10.3. Strategy framework
3.10.4. Recent Acquisitions & Mergers
4. Hemorrhoids Market, Product Type Segment Analysis
4.1. Overview Dynamics
4.1.1. Market Revenue Share, By Product Type, 2025 & 2035
4.1.2. Key Market Trends, Growth Factors, & Opportunities
4.2. Drugs
4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.2.2. OTC
4.2.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.2.3. Prescription Drugs
4.2.3.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.3. Disease Types
4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.3.2. Hemorrhoid Banding Disease Types
4.3.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.3.3. Laser Treatment Disease Types
4.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.3.4. Cryotherapy Disease Types
4.3.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.4. Supplements
4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
5. Hemorrhoids Market, Disease Type Segment Analysis
5.1. Overview
5.1.1. Market Revenue Share, By Disease Type, 2025 & 2035
5.1.2. Key Market Trends, Growth Factors, & Opportunities
5.2. Internal Hemorrhoids
5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
5.3. External Hemorrhoids
5.3.1. Market Size and Forecast, By 2025-2035(USD Billion)
5.4. Prolapsed Hemorrhoids
5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
5.5. Thrombosed Hemorrhoids
5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)
6. Hemorrhoids Market, Treatment Type Segment Analysis
6.1. Overview
6.1.1. Market Revenue Share, By Treatment Type, 2025 & 2035
6.1.2. Key Market Trends, Growth Factors, & Opportunities
6.2. Surgical Treatments
6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
6.3. Hemorrhoidectomy
6.3.1. Market Size and Forecast, By 2025-2035(USD Billion)
6.4. Stapled Hemorrhoidopexy
6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
6.5. Non-surgical Treatments
6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)
6.6. Medications
6.6.1. Market Size and Forecast, 2025-2035 (USD Billion)
6.7. Minimally Invasive Procedures
6.7.1. Market Size and Forecast, 2025-2035 (USD Billion)
7. Hemorrhoids Market, Route of Administration Segment Analysis
7.1. Overview
7.1.1. Market Revenue Share, By Route of Administration, 2025 & 2035
7.1.2. Key Market Trends, Growth Factors, & Opportunities
7.2. Topical
7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
7.3. Oral
7.3.1. Market Size and Forecast, By 2025-2035(USD Billion)
7.4. Injectable
7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
8. Hemorrhoids Market, End-user Segment Analysis
8.1. Overview
8.1.1. Market Revenue Share, By End-user, 2025 & 2035
8.1.2. Key Market Trends, Growth Factors, & Opportunities
8.2. Hospitals
8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
8.3. Clinics
8.3.1. Market Size and Forecast, By 2025-2035(USD Billion)
8.4. Ambulatory Surgical Centers
8.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
8.5. Home Care Settings
8.5.1. Market Size and Forecast, 2025-2035 (USD Billion)
9. Hemorrhoids Market, Region Segment Analysis
9.1. Overview
9.1.1. Global Market Revenue Share, By Region, 2025 & 2035
9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)
9.2. North America
9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)
9.2.2. North America Market Revenue, By Product Type, 2025-2035
9.2.3. North America Market Revenue, By Disease Type, 2025-2035
9.2.4. North America Market Revenue, By Treatment Type, 2025-2035
9.2.5. North America Market Revenue, By Route of Administration, 2025-2035
9.2.6. North America Market Revenue, By End-user, 2025-2035
9.2.7. The U.S.
9.2.7.1. U.S. Market Revenue, By Product Type, 2025-2035
9.2.7.2. U.S. Market Revenue, By Disease Type, 2025-2035
9.2.7.3. U.S. Market Revenue, By Treatment Type, 2025-2035
9.2.7.4. U.S. Market Revenue, By Route of Administration, 2025-2035
9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035
9.2.8. Canada
9.2.8.1. Canada Market Revenue, By Product Type, 2025-2035
9.2.8.2. Canada Market Revenue, By Disease Type, 2025-2035
9.2.8.3. Canada Market Revenue, By Treatment Type, 2025-2035
9.2.8.4. Canada Market Revenue, By Route of Administration, 2025-2035
9.2.8.5. Canada Market Revenue, By End-user, 2025-2035
9.3. Europe
9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)
9.3.2. Europe Market Revenue, By Product Type, 2025-2035
9.3.3. Europe Market Revenue, By Disease Type, 2025-2035
9.3.4. Europe Market Revenue, By Treatment Type, 2025-2035
9.3.5. Europe Market Revenue, By Route of Administration, 2025-2035
9.3.6. Europe Market Revenue, By End-user, 2025-2035
9.3.7. Germany
9.3.7.1. Germany Market Revenue, By Product Type, 2025-2035
9.3.7.2. Germany Market Revenue, By Disease Type, 2025-2035
9.3.7.3. Germany Market Revenue, By Treatment Type, 2025-2035
9.3.7.4. Germany Market Revenue, By Route of Administration, 2025-2035
9.3.7.5. Germany Market Revenue, By End-user, 2025-2035
9.3.8. France
9.3.8.1. France Market Revenue, By Product Type, 2025-2035
9.3.8.2. France Market Revenue, By Disease Type, 2025-2035
9.3.8.3. France Market Revenue, By Treatment Type, 2025-2035
9.3.8.4. France Market Revenue, By Route of Administration, 2025-2035
9.3.8.5. France Market Revenue, By End-user, 2025-2035
9.3.9. U.K.
9.3.9.1. U.K. Market Revenue, By Product Type, 2025-2035
9.3.9.2. U.K. Market Revenue, By Disease Type, 2025-2035
9.3.9.3. U.K. Market Revenue, By Treatment Type, 2025-2035
9.3.9.4. U.K. Market Revenue, By Route of Administration, 2025-2035
9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035
9.3.10. Italy
9.3.10.1. Italy Market Revenue, By Product Type, 2025-2035
9.3.10.2. Italy Market Revenue, By Disease Type, 2025-2035
9.3.10.3. Italy Market Revenue, By Treatment Type, 2025-2035
9.3.10.4. Italy Market Revenue, By Route of Administration, 2025-2035
9.3.10.5. Italy Market Revenue, By End-user, 2025-2035
9.3.11. Spain
9.3.11.1. Spain Market Revenue, By Product Type, 2025-2035
9.3.11.2. Spain Market Revenue, By Disease Type, 2025-2035
9.3.11.3. Spain Market Revenue, By Treatment Type, 2025-2035
9.3.11.4. Spain Market Revenue, By Route of Administration, 2025-2035
9.3.11.5. Spain Market Revenue, By End-user, 2025-2035
9.3.12. Rest of Europe
9.3.12.1. Rest of Europe Market Revenue, By Product Type, 2025-2035
9.3.12.2. Rest of Europe Market Revenue, By Disease Type, 2025-2035
9.3.12.3. Rest of Europe Market Revenue, By Treatment Type, 2025-2035
9.3.12.4. Rest of Europe Market Revenue, By Route of Administration, 2025-2035
9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035
9.4. Asia Pacific
9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)
9.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035
9.4.3. Asia Pacific Market Revenue, By Disease Type, 2025-2035
9.4.4. Asia Pacific Market Revenue, By Treatment Type, 2025-2035
9.4.5. Asia Pacific Market Revenue, By Route of Administration, 2025-2035
9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035
9.4.7. China
9.4.7.1. China Market Revenue, By Product Type, 2025-2035
9.4.7.2. China Market Revenue, By Disease Type, 2025-2035
9.4.7.3. China Market Revenue, By Treatment Type, 2025-2035
9.4.7.4. China Market Revenue, By Route of Administration, 2025-2035
9.4.7.5. China Market Revenue, By End-user, 2025-2035
9.4.8. Japan
9.4.8.1. Japan Market Revenue, By Product Type, 2025-2035
9.4.8.2. Japan Market Revenue, By Disease Type, 2025-2035
9.4.8.3. Japan Market Revenue, By Treatment Type, 2025-2035
9.4.8.4. Japan Market Revenue, By Route of Administration, 2025-2035
9.4.8.5. Japan Market Revenue, By End-user, 2025-2035
9.4.9. India
9.4.9.1. India Market Revenue, By Product Type, 2025-2035
9.4.9.2. India Market Revenue, By Disease Type, 2025-2035
9.4.9.3. India Market Revenue, By Treatment Type, 2025-2035
9.4.9.4. India Market Revenue, By Route of Administration, 2025-2035
9.4.9.5. India Market Revenue, By End-user, 2025-2035
9.4.10. Australia
9.4.10.1. Australia Market Revenue, By Product Type, 2025-2035
9.4.10.2. Australia Market Revenue, By Disease Type, 2025-2035
9.4.10.3. Australia Market Revenue, By Treatment Type, 2025-2035
9.4.10.4. Australia Market Revenue, By Route of Administration, 2025-2035
9.4.10.5. Australia Market Revenue, By End-user, 2025-2035
9.4.11. South Korea
9.4.11.1. South Korea Market Revenue, By Product Type, 2025-2035
9.4.11.2. South Korea Market Revenue, By Disease Type, 2025-2035
9.4.11.3. South Korea Market Revenue, By Treatment Type, 2025-2035
9.4.11.4. South Korea Market Revenue, By Route of Administration, 2025-2035
9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035
9.4.12. Singapore
9.4.12.1. Singapore Market Revenue, By Product Type, 2025-2035
9.4.12.2. Singapore Market Revenue, By Disease Type, 2025-2035
9.4.12.3. Singapore Market Revenue, By Treatment Type, 2025-2035
9.4.12.4. Singapore Market Revenue, By Route of Administration, 2025-2035
9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035
9.4.13. Rest of Asia Pacific
9.4.13.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035
9.4.13.2. Rest of Asia Pacific Market Revenue, By Disease Type, 2025-2035
9.4.13.3. Rest of Asia Pacific Market Revenue, By Treatment Type, 2025-2035
9.4.13.4. Rest of Asia Pacific Market Revenue, By Route of Administration, 2025-2035
9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035
9.5. Latin America
9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)
9.5.2. Latin America Market Revenue, By Product Type, 2025-2035
9.5.3. Latin America Market Revenue, By Disease Type, 2025-2035
9.5.4. Latin America Market Revenue, By Treatment Type, 2025-2035
9.5.5. Latin America Market Revenue, By Route of Administration, 2025-2035
9.5.6. Latin America Market Revenue, By End-user, 2025-2035
9.5.7. Brazil
9.5.7.1. Brazil Market Revenue, By Product Type, 2025-2035
9.5.7.2. Brazil Market Revenue, By Disease Type, 2025-2035
9.5.7.3. Brazil Market Revenue, By Treatment Type, 2025-2035
9.5.7.4. Brazil Market Revenue, By Route of Administration, 2025-2035
9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035
9.5.8. Argentina
9.5.8.1. Argentina Market Revenue, By Product Type, 2025-2035
9.5.8.2. Argentina Market Revenue, By Disease Type, 2025-2035
9.5.8.3. Argentina Market Revenue, By Treatment Type, 2025-2035
9.5.8.4. Argentina Market Revenue, By Route of Administration, 2025-2035
9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035
9.5.9. Mexico
9.5.9.1. Mexico Market Revenue, By Product Type, 2025-2035
9.5.9.2. Mexico Market Revenue, By Disease Type, 2025-2035
9.5.9.3. Mexico Market Revenue, By Treatment Type, 2025-2035
9.5.9.4. Mexico Market Revenue, By Route of Administration, 2025-2035
9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035
9.5.10. Rest of Latin America
9.5.10.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035
9.5.10.2. Rest of Latin America Revenue, By Disease Type, 2025-2035
9.5.10.3. Rest of Latin America Market Revenue, By Treatment Type, 2025-2035
9.5.10.4. Rest of Latin America Market Revenue, By Route of Administration, 2025-2035
9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035
9.6. MEA
9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)
9.6.2. MEA Market Revenue, By Product Type, 2025-2035
9.6.3. MEA Market Revenue, By Disease Type, 2025-2035
9.6.4. MEA Market Revenue, By Treatment Type, 2025-2035
9.6.5. MEA Market Revenue, By Route of Administration, 2025-2035
9.6.6. MEA Market Revenue, By End-user, 2025-2035
9.6.7. GCC Countries
9.6.7.1. GCC Countries Market Revenue, By Product Type, 2025-2035
9.6.7.2. GCC Countries Market Revenue, By Disease Type, 2025-2035
9.6.7.3. GCC Countries Market Revenue, By Treatment Type, 2025-2035
9.6.7.4. GCC Countries Market Revenue, By Route of Administration, 2025-2035
9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035
9.6.8. South Africa
9.6.8.1. South Africa Market Revenue, By Product Type, 2025-2035
9.6.8.2. South Africa Market Revenue, By Disease Type, 2025-2035
9.6.8.3. South Africa Market Revenue, By Treatment Type, 2025-2035
9.6.8.4. South Africa Market Revenue, By Route of Administration, 2025-2035
9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035
9.6.9. Rest of Middle-East &Africa
9.6.9.1. Rest of Middle-East &Africa Market Revenue, By Product Type, 2025-2035
9.6.9.2. Rest of Middle-East& Africa Market Revenue, By Disease Type, 2025-2035
9.6.9.3. Rest of Middle-East &Africa Market Revenue, ByTreatment Type, 2025-2035
9.6.9.4. Rest of Middle-East&Africa Market Revenue, By Route of Administration, 2025-2035
9.6.9.5. Rest of Middle-East &Africa Market Revenue, By End-user, 2025-2035
10. Company Profile
10.1. Medtronic plc
10.1.1. Business Overview
10.1.2. Financial Performance
10.1.3. Product/Service Offerings
10.1.4. Strategies & recent developments
10.1.5. SWOT Analysis
10.2. Boston Scientific Corporation
10.2.1. Business Overview
10.2.2. Financial Performance
10.2.3. Product/Service Offerings
10.2.4. Strategies & recent developments
10.2.5. SWOT Analysis
10.3. Johnson & Johnson
10.3.1. Business Overview
10.3.2. Financial Performance
10.3.3. Product/Service Offerings
10.3.4. Strategies & recent developments
10.3.5. SWOT Analysis
10.4. Stryker Corporation
10.4.1. Business Overview
10.4.2. Financial Performance
10.4.3. Product/Service Offerings
10.4.4. Strategies & recent developments
10.4.5. SWOT Analysis
10.5. Cook Medical
10.5.1. Business Overview
10.5.2. Financial Performance
10.5.3. Product/Service Offerings
10.5.4. Strategies & recent developments
10.5.5. SWOT Analysis
10.6. Alcon
10.6.1. Business Overview
10.6.2. Financial Performance
10.6.3. Product/Service Offerings
10.6.4. Strategies & recent developments
10.6.5. SWOT Analysis
10.7. B. Braun Melsungen AG
10.7.1. Business Overview
10.7.2. Financial Performance
10.7.3. Product/Service Offerings
10.7.4. Strategies & recent developments
10.7.5. SWOT Analysis
10.8. Coloplast A/S
10.8.1. Business Overview
10.8.2. Financial Performance
10.8.3. Product/Service Offerings
10.8.4. Strategies & recent developments
10.8.5. SWOT Analysis
10.9. Halyard Health
10.9.1. Business Overview
10.9.2. Financial Performance
10.9.3. Product/Service Offerings
10.9.4. Strategies & recent developments
10.9.5. SWOT Analysis
10.10. Cynosure
10.10.1. Business Overview
10.10.2. Financial Performance
10.10.3. Product/Service Offerings
10.10.4. Strategies & recent developments
10.10.5. SWOT Analysis
10.11. Penumbra, Inc.
10.11.1. Business Overview
10.11.2. Financial Performance
10.11.3. Product/Service Offerings
10.11.4. Strategies & recent developments
10.11.5. SWOT Analysis
10.12. Aesculap
10.12.1. Business Overview
10.12.2. Financial Performance
10.12.3. Product/Service Offerings
10.12.4. Strategies & recent developments
10.12.5. SWOT Analysis
10.13. Medline Industries, Inc.
10.13.1. Business Overview
10.13.2. Financial Performance
10.13.3. Product/Service Offerings
10.13.4. Strategies & recent developments
10.13.5. SWOT Analysis
10.14. Conmed Corporation
10.14.1. Business Overview
10.14.2. Financial Performance
10.14.3. Product/Service Offerings
10.14.4. Strategies & recent developments
10.14.5. SWOT Analysis
10.15. Hologic, Inc.
10.15.1. Business Overview
10.15.2. Financial Performance
10.15.3. Product/Service Offerings
10.15.4. Strategies & recent developments
10.15.5. SWOT Analysis
List of Tables
TABLE 1. GLOBAL HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 2. GLOBAL HEMORRHOIDS MARKET VALUE FOR ACTIVATED CARBON, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 3. GLOBAL HEMORRHOIDS MARKET VALUE FOR CARBON DERIVATIVES, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 4. GLOBAL HEMORRHOIDS MARKET VALUE FOR METAL OXIDES, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 5. GLOBAL HEMORRHOIDS MARKET VALUE FOR CONDUCTIVE POLYMERS, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 6. GLOBAL HEMORRHOIDS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 7. GLOBAL HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 8. GLOBAL HEMORRHOIDS MARKET VALUE FOR CONSUMER ELECTRONICS, 2025-2035 (USD BILLION)
TABLE 9. GLOBAL HEMORRHOIDS MARKET VALUE FOR INDUSTRIAL, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 10. GLOBAL HEMORRHOIDS MARKET VALUE FOR TRANSPORTATION, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 11. GLOBAL HEMORRHOIDS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 12. NORTH AMERICA HEMORRHOIDS MARKET VALUE, BY COUNTRY, 2025-2035 (USD BILLION)
TABLE 13. NORTH AMERICA HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 14. NORTH AMERICA HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 15. U.S HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 16. U.S HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 17. CANADA HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 18. CANADA HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 19. EUROPE HEMORRHOIDS MARKET VALUE, BY COUNTRY, 2025-2035 (USD BILLION)
TABLE 20. EUROPE HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 21. EUROPE HEMORRHOIDS MARKET VALUE, TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 22. GERMANY HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 23. GERMANY HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 24. U.K HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 25. U.K HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 26. FRANCE HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 27. FRANCE HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 28. ITALY HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 29. ITALY HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 30. SPAIN HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 31. SPAIN HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 32. ROE HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 33. ROE HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 34. ASIA PACIFIC HEMORRHOIDS MARKET VALUE, BY COUNTRY, 2025-2035 (USD BILLION)
TABLE 35. ASIA PACIFIC HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 36. ASIA PACIFIC HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 37. CHINA HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 38. CHINA HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 39. INDIA HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 40. INDIA HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 41. JAPAN HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 42. JAPAN HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 43. REST OF APAC HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 44. REST OF APAC HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 45. REST OF WORLD HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
TABLE 46. REST OF WORLD HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 47. CABOT(NORIT): FINANCIALS
TABLE 48. CABOT(NORIT): PRODUCTS & SERVICES
TABLE 49. CABOT(NORIT): RECENT DEVELOPMENTS
TABLE 50. KURARY CO. LTD: FINANCIALS
TABLE 51. KURARY CO. LTD: PRODUCTS & SERVICES
TABLE 52. KURARY CO. LTD: RECENT DEVELOPMENTS
TABLE 53. BAYER MATERIALSCIENCE AG: FINANCIALS
TABLE 54. BAYER MATERIALSCIENCE AG: PRODUCTS & SERVICES
TABLE 55. BAYER MATERIALSCIENCE AG: RECENT DEVELOPMENTS
TABLE 56. CALGON CARBON CORPORATION: FINANCIALS
TABLE 57. CALGON CARBON CORPORATION: PRODUCTS & SERVICES
TABLE 58. CALGON CARBON CORPORATION: RECENT DEVELOPMENTS
TABLE 59. CARBON NT&F: FINANCIALS
TABLE 60. CARBON NT&F: PRODUCTS & SERVICES
TABLE 61. CARBON NT&F: RECENT DEVELOPMENTS
TABLE 62. SHENZHEN NTP: FINANCIALS
TABLE 63. SHENZHEN NTP: PRODUCTS & SERVICES
TABLE 64. SHENZHEN NTP: RECENT DEVELOPMENTS
TABLE 65. CECA SA: FINANCIALS
TABLE 66. CECA SA: PRODUCTS & SERVICES
TABLE 67. CECA SA: RECENT DEVELOPMENTS
TABLE 68. CNANO TECHNOLOGY: FINANCIALS
TABLE 69. CNANO TECHNOLOGY: PRODUCTS & SERVICES
TABLE 70. CNANO TECHNOLOGY: RECENT DEVELOPMENTS
TABLE 71. DONAU CHEMIE GROUP: FINANCIALS
TABLE 72. DONAU CHEMIE GROUP: PRODUCTS & SERVICES
TABLE 73. DONAU CHEMIE GROUP: RECENT DEVELOPMENTS
TABLE 74. SHOWA DENKO: FINANCIALS
TABLE 75. SHOWA DENKO: PRODUCTS & SERVICES
TABLE 76. SHOWA DENKO: RECENT DEVELOPMENTS
List of Figures
CHART 1. GLOBAL HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 2. GLOBAL HEMORRHOIDS MARKET VALUE FOR ACTIVATED CARBON, BY GEOGRAPHY, 2025-2035 (USD BILLION)
CHART 3. GLOBAL HEMORRHOIDS MARKET VALUE FOR CARBON DERIVATIVES, BY GEOGRAPHY, 2025-2035 (USD BILLION)
CHART 4. GLOBAL HEMORRHOIDS MARKET VALUE FOR METAL OXIDES, BY GEOGRAPHY, 2025-2035 (USD BILLION)
CHART 5. GLOBAL HEMORRHOIDS MARKET VALUE FOR CONDUCTIVE POLYMERS, BY GEOGRAPHY, 2025-2035 (USD BILLION)
CHART 6. GLOBAL HEMORRHOIDS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2025-2035 (USD BILLION)
CHART 7. GLOBAL HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
CHART 8. GLOBAL HEMORRHOIDS MARKET VALUE FOR CONSUMER ELECTRONICS, 2025-2035 (USD BILLION)
CHART 9. GLOBAL HEMORRHOIDS MARKET VALUE FOR INDUSTRIAL, BY GEOGRAPHY, 2025-2035 (USD BILLION)
CHART 10. GLOBAL HEMORRHOIDS MARKET VALUE FOR TRANSPORTATION, BY GEOGRAPHY, 2025-2035 (USD BILLION)
CHART 11. GLOBAL HEMORRHOIDS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2025-2035 (USD BILLION)
CHART 12. NORTH AMERICA HEMORRHOIDS MARKET VALUE, BY COUNTRY, 2025-2035 (USD BILLION)
CHART 13. NORTH AMERICA HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 14. NORTH AMERICA HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
CHART 15. U.S HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 16. U.S HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
CHART 17. CANADA HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 18. CANADA HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
CHART 19. EUROPE HEMORRHOIDS MARKET VALUE, BY COUNTRY, 2025-2035 (USD BILLION)
CHART 20. EUROPE HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 21. EUROPE HEMORRHOIDS MARKET VALUE, TREATMENT TYPE, 2025-2035 (USD BILLION)
CHART 22. GERMANY HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 23. GERMANY HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
CHART 24. U.K HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 25. U.K HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
CHART 26. FRANCE HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 27. FRANCE HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
CHART 28. ITALY HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 29. ITALY HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
CHART 30. SPAIN HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 31. SPAIN HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
CHART 32. ROE HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 33. ROE HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
CHART 34. ASIA PACIFIC HEMORRHOIDS MARKET VALUE, BY COUNTRY, 2025-2035 (USD BILLION)
CHART 35. ASIA PACIFIC HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 36. ASIA PACIFIC HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
CHART 37. CHINA HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 38. CHINA HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
CHART 39. INDIA HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 40. INDIA HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
CHART 41. JAPAN HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 42. JAPAN HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
CHART 43. REST OF APAC HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 44. REST OF APAC HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
CHART 45. REST OF WORLD HEMORRHOIDS MARKET VALUE, BY DISEASE TYPE, 2025-2035 (USD BILLION)
CHART 46. REST OF WORLD HEMORRHOIDS MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)

Companies Mentioned

  • Medtronic plc
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Stryker Corporation
  • Cook Medical
  • Alcon
  • B. Braun Melsungen AG
  • Coloplast A/S
  • Halyard Health
  • Cynosure
  • Penumbra, Inc.
  • Aesculap
  • Medline Industries, Inc.
  • Conmed Corporation
  • Hologic, Inc.

Related Topics

Related Reports

Disposable Hemorrhoid Ligation Device Market by Product Type, End User, Application, Distribution Channel - Global Forecast to 2030 - Product Image

Disposable Hemorrhoid Ligation Device Market by Product Type, End User, Application, Distribution Channel - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Hemorrhoids - Pipeline Insight, 2025 - Product Image

Hemorrhoids - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Hemorrhoid Treatment Devices Market by Product Type, End User, Distribution Channel, Payer Type - Global Forecast to 2030 - Product Image

Hemorrhoid Treatment Devices Market by Product Type, End User, Distribution Channel, Payer Type - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Hemorrhoids - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Hemorrhoids - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Hemorrhoid Treatment Device Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Hemorrhoid Treatment Device Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Hemorrhoid Market

Hemorrhoids are a common condition affecting the lower rectum and anus. They are caused by increased pressure in the veins of the rectum and anus, which can be caused by straining during bowel movements, pregnancy, or obesity. Symptoms of hemorrhoids include itching, pain, and bleeding. Treatment options for hemorrhoids include lifestyle changes, topical medications, and surgical procedures. Gastroenterology is a medical specialty that focuses on the diagnosis and treatment of diseases of the digestive system. Hemorrhoids are a common condition that falls within the scope of gastroenterology. Gastroenterologists are trained to diagnose and treat hemorrhoids, as well as provide advice on lifestyle changes to reduce the risk of developing hemorrhoids. The hemorrhoid market includes a variety of products and services, such as topical medications, surgical procedures, and lifestyle advice. Companies in the market include Allergan, GlaxoSmithKline, Pfizer, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.